Maternal Omega-3 Supplementation to Reduce Bronchopulmonary Dysplasia
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Bronchopulmonary Dysplasia
- Child Development
- Neonatal and Perinatal Conditions
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 16 years and 125 years
- Gender
- Only males
Description
Every year in Canada, 1500 babies who are born early (prematurely) develop a serious lung disease called bronchopulmonary dysplasia (BPD). BPD causes major health problems in these infants, especially in their early childhood. In most situations, breast-milk is the ideal source of nutrition for grow...
Every year in Canada, 1500 babies who are born early (prematurely) develop a serious lung disease called bronchopulmonary dysplasia (BPD). BPD causes major health problems in these infants, especially in their early childhood. In most situations, breast-milk is the ideal source of nutrition for growth and development of premature babies. However, diets of Canadian mothers are generally deficient in omega-3 lipids (essential fats), resulting in lower protection from these omega-3 lipids in mother's milk-fed infants. Previous research has shown that giving DHA to mothers of premature babies is safe both for the mother and for their baby, and is an efficient way of helping babies meet their dietary requirements from breast-milk. Furthermore, this previous research also suggests that this intervention may reduce the risk of BPD in premature babies receiving breast-milk.
Tracking Information
- NCT #
- NCT02371460
- Collaborators
- Canadian Institutes of Health Research (CIHR)
- Laval University
- Investigators
- Principal Investigator: Isabelle Marc, MD,PhD CHU de Quebec, Université Laval Principal Investigator: Pascal Lavoie, MD, PhD Children's and Women's Health Centre of BC, University of British Columbia Principal Investigator: Mâsse Benoît, PhD CHU Sainte-Justine, Université de Montreal Principal Investigator: Thierry Lacaze, MD, PhD Children's Hospital of Eastern Ontario, University of Ottawa Principal Investigator: Anne-Monique Nuyt, MD, PhD CHU Sainte-Justine, Université de Montreal Principal Investigator: William Fraser, MD, MSc Université de Sherbrooke
Get Well Soon